Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | PLAT | P00750 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1865236 | 0.85 | PLAT (0.40) | NPC1PKMKMT2AL3MBTL1CYP1A2 | |
| SCHEMBL1865999 | 0.83 | PKM (0.40) | NPC1PKMMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL841191 | 0.78 | MEN1 (0.56) | NPC1PKMMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL4625215 | 0.78 | NPC1 (0.48) | NPC1PKMMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL16626084 | 0.71 | PKM (0.50) | NPC1PKMMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL18740019 | 0.70 | GAA (0.38) | NPC1PKMGAAPLATPOLB | |
| SCHEMBL6606222 | 0.69 | NPC1 (0.39) | NPC1PKMMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL18740293 | 0.68 | GAA (0.36) | NPC1PKMGAAALDH1A1PLAT | |
| SCHEMBL8787277 | 0.68 | KMT2A (0.44) | NPC1PKMKMT2ASMN1; SMN2L3MBTL1 | |
| SCHEMBL28753841 | 0.68 | NPC1 (0.41) | NPC1PKMMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7939673-B2 | Process for preparing 3-dihalomethyl-pyrazole-4-carboxylic acid derivatives | BAYER CROPSCIENCE AG (DE) | 2011-05-10 | — | — | US | disclosed |
| US-20090326242-A1 | PROCESS FOR PREPARING 3-DIHALOMETHYL-PYRAZOLE-4-CARBOXYLIC ACID DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090326242-A1 | PROCESS FOR PREPARING 3-DIHALOMETHYL-PYRAZOLE-4-CARBOXYLIC ACID DERIVATIVES | HRH4, SUV39H2, SUV39H1 | NPC1 4852/4885PKM 604/4885MEN1 1916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.